Multiple Sclerosis Journal
The Multiple Sclerosis Journal (MSJ) is the sole official journal of ECTRIMS.
Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system.
The journal for your research in the following areas:
- Biologic basis: pathology, myelin biology, the pathophysiology of the blood-brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics
- Epidemiology and genetics: genetics epigenetics, epidemiology
- Clinical and neuroimaging: clinical neurology, biomarkers, neuroimaging and clinical outcome measures
- Therapeutics and rehabilitation: therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management
Outstanding information presented in a topical based format.
This journal is a member of the Committee on Publication Ethics (COPE).
Now free to access:
Controversies in MS: a series of debates published regularly in the journal since October 2011. Read both sides of the debate on a wide range of key topics.
Topical reviews are also free to read in MSJ and are amongst MSJ’s most downloaded articles, these reviews are both succinct and up-to-date.
The President of ECTRIMS is co-editor of the Multiple Sclerosis Journal.
For further information please visit http://msj.sagepub.com.